jueves, 19 de noviembre de 2026

Oncology News: Higher Melphalan Exposure Tied to Deeper Myeloma Responses (+...)

Oncology News Higher Melphalan Exposure Tied to Deeper Myeloma Responses A phase 1/2 trial explores dose and infusion schedule optimization of a propylene glycol-free melphalan formulation in patients with newly diagnosed myeloma undergoing autologous stem cell transplant. Medscape Medical News, November 19, 2026 https://www.medscape.com/index/list_13474_0

No hay comentarios:

Publicar un comentario